Electrical cardioversion for Atrial Fibrillation

University of Ottawa Heart Institute, Ottawa, Canada
Atrial FibrillationElectrical cardioversion - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare quality of life in patients with atrial fibrillation who undergo electrical cardioversion to those who undergo a sham procedure.

Treatment Effectiveness

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 4 weeks

4 weeks
Absolute AFEQT score post-cardioversion
Change in daily activity
Change in generic quality of life
Difference between AFEQT Scores pre and post cardioversion
Study exit questionnaire on patient's perceived well-being

Trial Safety

Trial Design

2 Treatment Groups

True cardioversion
1 of 2
Sham cardioversion
1 of 2

Experimental Treatment

Non-Treatment Group

100 Total Participants · 2 Treatment Groups

Primary Treatment: Electrical cardioversion · Has Placebo Group · N/A

True cardioversion
Procedure
Experimental Group · 1 Intervention: Electrical cardioversion · Intervention Types: Procedure
Sham cardioversion
Other
ShamComparator Group · 1 Intervention: Sham electrical cardioversion · Intervention Types: Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Electrical cardioversion
2014
N/A
~440

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks

Who is running the clinical trial?

Ottawa Heart Institute Research CorporationLead Sponsor
181 Previous Clinical Trials
91,248 Total Patients Enrolled
23 Trials studying Atrial Fibrillation
6,591 Patients Enrolled for Atrial Fibrillation
David Birnie, MDPrincipal InvestigatorOttawa Heart Institute Research Corporation
4 Previous Clinical Trials
3,147 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have ongoing atrial fibrillation.
We don't know how much your symptoms are related to atrial fibrillation.

Frequently Asked Questions

Are there vacancies remaining in this clinical assessment?

"According to the clinicaltrials.gov records, this trial is not actively seeking patients; it was first posted on December 20th 2022 and last edited November 18th 2022. Nonetheless, there are currently 477 different studies that are open for enrollment right now." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.